Erythromycin

• Catalog No.: Erythromycin
• CAS Number: 114-07-8
• M. F.: C37H67NO13
• M. W.: 733.92678

SYNONYMS

• IUPAC name: (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy}-3,5,7,9,11,13-hexamethyl-1-oxacyclotetradecane-2,10-dione
• IUPAC Traditional name: erythromycin
• Brand Name: E-mycin, Erythrocin

DATABASE IDS

• CAS Number: 114-07-8
• CHEMBL: 532
• Wikipedia Title: Erythromycin
• ATC CODE: D10AF02
• DrugBank ID: DB00199
• KEGG ID: D00140
• PubChem CID: 3255
• Chemspider ID: 12041
• Unique Ingredient Identifier: 63937KV33D
• Medline Plus: a682381
• ATC CODE: S01AA17
• ATC CODE: QJ51FA01
• CHEBI ID: 42355
• ATC CODE: J01FA01
• IUPHAR ligand ID: 1456

PROPERTIES

• Admin Routes: oral, iv, im, topical, ophthalmic eye drops
• Bioavailability: Depends on the ester type between 30% - 65%
• Excretion: bile
• Half Life: 1.5 hours
• Legal Status: S4 (Australia)
• Legal Status: POM (UK)
• Legal Status: Rx-only (US)
• Metabolism: liver (under 5% excreted unchanged)
• Pregnancy Category: B (US)
• Pregnancy Category: A (Australia)
• Protein Bound: 90%